We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety Disorder

This study has been terminated.
(Pfizer has terminated the execution of this protocol)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00836069
First Posted: February 4, 2009
Last Update Posted: June 1, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Pfizer
Information provided by:
Cedars-Sinai Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: April 2010
  Estimated Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)